BACKGROUND: Multiple sclerosis (MS) predominantly affects women with a sex ratio of 3:1 in contrast with a 1:1 sex ratio seen in pre-pubertal onset. Thus, puberty may influence MS risk differentially in males and females. How puberty may be associated with MS clinical features and disease course remains unknown. OBJECTIVE: The objective of this paper is to determine the association of menarche with disease course in girls with MS. METHODS: This is a longitudinal retrospective study from the UCSF Regional Pediatric MS Center database. We categorized patients by time of disease onset: pre-menarche, peri-menarche and post-menarche. Poisson regression models were used for within-subject relapse analyses offset by follow-up time. RESULTS: Seventy-six girls were included (pre-menarche onset = 17; peri-menarche onset = 9; post-menarche onset = 50). Age of menarche was similar in all groups (Kruskal-Wallis p = 0.19). Relapse rate was the same in all three groups during the first two years of follow-up. In girls with follow-up overlapping at least two time periods, within-subject analyses showed increased relapses during the peri-menarche compared to post-menarche period (adjusted IRR = 8.5, 95% CI 2.5-28.7, p = 0.001). CONCLUSION: Pubertal status may influence MS course at least in female patients. Understanding how puberty influences MS clinical features may offer new insights into important factors regulating disease processes.
BACKGROUND:Multiple sclerosis (MS) predominantly affects women with a sex ratio of 3:1 in contrast with a 1:1 sex ratio seen in pre-pubertal onset. Thus, puberty may influence MS risk differentially in males and females. How puberty may be associated with MS clinical features and disease course remains unknown. OBJECTIVE: The objective of this paper is to determine the association of menarche with disease course in girls with MS. METHODS: This is a longitudinal retrospective study from the UCSF Regional Pediatric MS Center database. We categorized patients by time of disease onset: pre-menarche, peri-menarche and post-menarche. Poisson regression models were used for within-subject relapse analyses offset by follow-up time. RESULTS: Seventy-six girls were included (pre-menarche onset = 17; peri-menarche onset = 9; post-menarche onset = 50). Age of menarche was similar in all groups (Kruskal-Wallis p = 0.19). Relapse rate was the same in all three groups during the first two years of follow-up. In girls with follow-up overlapping at least two time periods, within-subject analyses showed increased relapses during the peri-menarche compared to post-menarche period (adjusted IRR = 8.5, 95% CI 2.5-28.7, p = 0.001). CONCLUSION: Pubertal status may influence MS course at least in female patients. Understanding how puberty influences MS clinical features may offer new insights into important factors regulating disease processes.
Authors: M B Horlick; M Rosenbaum; M Nicolson; L S Levine; B Fedun; J Wang; R N Pierson; R L Leibel Journal: J Clin Endocrinol Metab Date: 2000-07 Impact factor: 5.958
Authors: G Matarese; A Di Giacomo; V Sanna; G M Lord; J K Howard; A Di Tuoro; S R Bloom; R I Lechler; S Zappacosta; S Fontana Journal: J Immunol Date: 2001-05-15 Impact factor: 5.422
Authors: S V Ramagopalan; W Valdar; M Criscuoli; G C DeLuca; D A Dyment; S-M Orton; I M Yee; G C Ebers; A D Sadovnick Journal: Eur J Neurol Date: 2009-03 Impact factor: 6.089
Authors: Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky Journal: Ann Neurol Date: 2011-02 Impact factor: 10.422
Authors: Anita L Belman; Lauren B Krupp; Cody S Olsen; John W Rose; Greg Aaen; Leslie Benson; Tanuja Chitnis; Mark Gorman; Jennifer Graves; Yolander Harris; Tim Lotze; Jayne Ness; Moses Rodriguez; Jan-Mendelt Tillema; Emmanuelle Waubant; Bianca Weinstock-Guttman; T Charles Casper Journal: Pediatrics Date: 2016-07 Impact factor: 7.124
Authors: Riley Bove; Liene Elsone; Enrique Alvarez; Nadja Borisow; Melissa M Cortez; Farrah J Mateen; Maureen A Mealy; Kerry Mutch; Sean Tobyne; Klemens Ruprecht; Guy Buckle; Michael Levy; Dean M Wingerchuk; Friedemann Paul; Anne H Cross; Brian Weinshenker; Anu Jacob; Eric C Klawiter; Tanuja Chitnis Journal: Neurol Neuroimmunol Neuroinflamm Date: 2017-03-24
Authors: Sherif M Hamdy; Maged Abdel-Naseer; Nevin M Shalaby; Alaa Elmazny; Marian Girgis; Mona A Nada; Amr Hassan; Husam S Mourad; Mohamed I Hegazy; Ahmed Abdelalim; Nirmeen A Kishk; Noha T Abokrysha; Shaimaa A Genedy; Ehab A Essawy; Hatem S Shehata Journal: Neuropsychiatr Dis Treat Date: 2018-02-23 Impact factor: 2.570